Infectious Disease
Conditions
Keywords
Delirium, Antibiotics, Older adults, Urinary Tract Infection
Brief summary
Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients experiencing delirium have bacteria in their urine, however, bacteria in the urine is common among older adults, and does not automatically indicate an infection is present. As a result it is difficult to know whether a lower urinary tract infection is present as individuals with delirium are frequently unable to report clinical signs of infection - symptoms of pain or discomfort with urination, having to urinate more frequently or pelvic discomfort. Very often, individuals with delirium are treated with antibiotics despite the fact that it is unknown whether antibiotics help to improve delirium in cases where bacteria in the urine is present. This proposed study is a randomized controlled trial that will examine if adults (age 60 or older) with delirium and suspected infection benefit from taking antibiotics.
Interventions
Participants will be randomized to start or continue with antibiotics (with antibiotic duration determined by the Most Responsible Physician \[MRP\]). Antibiotics choice to be selected by the MRP.
Participants will be randomized to no antibiotics
Sponsors
Study design
Eligibility
Inclusion criteria
* Age ≥ 60 and admitted to a hospital ward (including rehabilitation hospital); * Active delirium (defined by CAM: \[1\] inattention AND \[2\] acute and fluctuating level of consciousness, and either \[3\] disorganized thinking OR \[4\] altered mental status; OR physician's diagnosis) * Less than 24 hours of antibiotics (prior to trial assessment) * Either pyuria (defined as white blood cells detected on urinalysis or dipstick) or bacteriuria (defined as bacteria growing on urine culture)
Exclusion criteria
* Fever (temperature \> 37.9C or \> 100.2F) in the past 48 hours; * Signs of lower urinary tract infection symptoms (such as new dysuria) or upper urinary symptoms (such as costovertebral tenderness) * In the opinion of the treating physician, there is a reason apart from delirium and urine test results to treat with antibiotics (e.g., pneumonia) * Indwelling urinary catheter for \> 72 hours * Receipt of an antibiotic where a single dose suffices for the treatment of a UTI (such as Fosfomycin)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Delirium at day 7 or at day of hospital discharge, whichever is earliest | Delirium will be assessed at the first of day 7 or discharge | Delirium will be assessed using Confusion Assessment Method (CAM). CAM assesses 4 delirium features: \[1\] inattention, \[2\] acute and fluctuating level of consciousness, \[3\] disorganized thinking and \[4\] altered mental status. For a diagnosis of delirium by CAM, the patient must display feature \[1\] AND \[2\], AND EITHER \[3\] or \[4\]. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants with bacteremia (bacteria isolated in blood culture) | Up to 7 days | — |
| Number of participants who were transferred to Intensive Care Unit (ICU) | Up to 7 days | — |
| Number of participants who had a fall | Up to 7 days | — |
| Number of participants who were physically restrained | Up to 7 days | — |
| Length of hospitalization | Up to 30 days | — |
| Days of antibiotics | Up to 7 days | — |
| Number of participants with C. difficile infection | By 30 days | C. difficile will be defined as a combination of a positive microbiological test for C. difficile (if still hospitalized at the time of diagnosis), or self-reported diagnosis of C. difficile (provided the patient reported diarrhea and receipt of an antibiotic to treat C. difficile) |
| Number of participants who died | By 30 days | — |
| Number of participants who were readmitted to hospital | By 365 days | — |
| Number of participants who received antipsychotics | Up to 7 days | — |
Countries
Canada, United States